Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Biochem. 2010 Nov;43(16-17):1371-2. doi: 10.1016/j.clinbiochem.2010.08.017. Epub 2010 Aug 19.

Gelofusine affects the quality control performance of QuickVue point-of-care human chorionic gonadotropin test devices.

Author information

1
Department of Clinical Chemistry, Maastricht University Medical Centre, The Netherlands. douwe.de.boer@mumc.nl

Abstract

OBJECTIVE:

To characterize the influence of Gelofusine (succinylated gelatin) on the performance of point-of-care testing (POCT) for human chorionic gonadotropin (hCG) devices.

DESIGN AND METHODS:

Three brands of urine and urine/serum hCG POCT devices were verified.

RESULTS:

Succinylated gelatin affected the performance of the control band in the QuickVue hCG POCT devices. Alternative devices were not affected. The hCG test performance is not influenced.

CONCLUSIONS:

Gelofusine affects specifically the quality control performance of the QuickVue hCG POCT devices.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center